SXTC · China SXT Pharmaceuticals, Inc.
$0.07
+0.02 (+29.33%)
At close · Jul 30
Market Cap
$2.01M
Shares
38.22M
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2025-01-20 | Simon Lim Sze Beng |
Co-Chief Executive Officer |
Other↑
|
No Securities Owned
|
0 |
| 2025-01-20 | Chee Yong Lip |
Director |
Other↑
|
No Securities Owned
|
0 |
| 2022-05-10 | Liu Tong Tony |
Director |
Other↑
|
No Securities Owned
|
0 |
| 2022-01-31 | Pan Xiaodong Sean |
Chief Financial Officer |
Other↑
|
No Securities Owned
|
0 |
| 2021-05-22 | Ji Xiaodong |
Director |
Other↑
|
No Securities Owned
|
0 |
Legend
Buy — open-market purchase
Sell — open-market sale
↑ Shares acquired
↓ Shares disposed (gift, conversion, tax…)
Showing 1–5 of 5 transactions
Key facts
CIK
1723980
CUSIP
G2161P165